APA (7th ed.) Citation

SX, G., RL, Z., C, G., QY, Q., K, F., SB, Y., . . . ZT, L. (2026). Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs. Journal of medicinal chemistry, 69(11), 13966. https://doi.org/10.1021/acs.jmedchem.6c01353

Chicago Style (17th ed.) Citation

SX, Gan, et al. "Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs." Journal of Medicinal Chemistry 69, no. 11 (2026): 13966. https://doi.org/10.1021/acs.jmedchem.6c01353.

MLA (9th ed.) Citation

SX, Gan, et al. "Fluorinated Ultralong-Acting Neuromuscular Blocking Agent with Improved Activity Profile and Biosafety for the Development of Blockade and Reversal Partner Drugs." Journal of Medicinal Chemistry, vol. 69, no. 11, 2026, p. 13966, https://doi.org/10.1021/acs.jmedchem.6c01353.